Chinese-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are encouraged
to distribute the up-to-date English-language
VIS at the
same time as the translation.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
These translations do not contain the following
CDC updates:
- These translations do not contain the following CDC updates
- The main change is in Section 4, which now mentions Tdap.
- The NVICP and VAERS web addresses have also been updated
- The mortality rate for tetanus in Section 1 changed from 1 out of
10, to 2 out of 10 cases.
- The date changed to 5/17/07.
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an interim
VIS for hepatitis B. There are minor changes throughout, but the main
purpose of the update is to emphasize the birth dose for all children.
- A final version will be developed.
This translation does not contain the
following CDC updates:-
The meningococcal VIS has been updated slightly to incorporate ACIP's
new recommendation to vaccinate all children & adolescents 11-18 years
of age. The new VIS is dated (8/16/07); the change affects only the
first 2 paragraphs of Section 3. In the VIS News link on the CDC
website they say that providers needn't discard existing stocks of the
previous edition, but should be prepared to explain the updated
recommendation to their patients if they use the older version.
- The
Guillain-Barre Syndrome (second bullet just above section 6)
was changed slightly: "a few" was replaced by "some" to
reflect the additional cases that were reported.
This translation does not contain the
following CDC updates:
- CDC added
more information about Tdap vaccine for adults.
- There are
minor changes in Section 3 reflecting the ACIP's evolving recommendations
regarding use of Tdap vaccine during pregnancy.
Thanks to
the California Department of Health Services and the San Francisco
Department of Public Health for their translations.This page was updated on
March 13, 2008 |